Medications like Zepbound can assist individuals in shedding substantial amounts of weight and potentially alleviate complications associated with being overweight
Implications for Future Rheumatoid Arthritis Care While the findings are preliminary, they open the door to prospective clinical trials investigating GLP-1 receptor agonists as adjunctive therapy in rheumatic disease
The gut barrier is a dynamic system influenced by the composition of the intestinal microbiome and the activity of intercellular connections, regulated by hormones, dietary components, inflammatory mediators, and the enteric nervous system (ENS)
The company also reported its fiscal year 2025 results via the filing of Lexarias Form 10-K
In the UK, MASLD is a leading cause of cirrhosis and hepatocellular carcinoma, often requiring resource-intensive monitoring in secondary care
Conclusion GLP-1 receptor agonists represent a significant advancement in managing pediatric diabetes and obesity, providing options that directly address insulin resistance, promote weight loss and reduce risks from related comorbidities